| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:733595 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ADRB2 mRNA | CTD | PMID:22079256 |
| (5-hydroxyindol-3-yl)acetic acid | multiple interactions | ISO | RGD:2060 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Hydroxyindoleacetic Acid | CTD | PMID:2463453 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [[Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; more ... | CTD | PMID:12920204 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 PMID:14730417 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Epinephrine inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Epinephrine binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:14730417 PMID:12920204 |
| (R)-adrenaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Epinephrine results in increased activity of ADRB2 protein] which results in increased secretion of Histamine | CTD | PMID:11164953 |
| (R)-adrenaline | affects response to substance | ISO | RGD:2060 | 6480464 | ADRB2 affects the susceptibility to Epinephrine | CTD | PMID:16026475 |
| (R)-adrenaline | increases activity | ISO | RGD:2060 | 6480464 | Epinephrine results in increased activity of ADRB2 protein | CTD | PMID:11164953 |
| (R)-adrenaline | increases activity | ISO | RGD:733595 | 6480464 | Epinephrine results in increased activity of ADRB2 protein | CTD | PMID:1389726 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Epinephrine promotes the reaction [ADRBK1 protein results in increased phosphorylation of ADRB2 protein]; more ... | CTD | PMID:14722251 |
| (R)-adrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol inhibits the reaction [Epinephrine binds to and results in increased activity of ADRB2 protein] | CTD | PMID:16225854 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:10344530 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 PMID:10344530 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Norepinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Norepinephrine binds to and results in increased activity of ADRB2 protein | CTD | PMID:10344530 PMID:14730417 |
| (R)-noradrenaline | multiple interactions | ISO | RGD:2060 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Fenoterol affects the abundance of Norepinephrine] | CTD | PMID:7969507 |
| (S)-nicotine | multiple interactions | ISO | RGD:733595 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Nicotine results in increased expression of PTGS2]; more ... | CTD | PMID:17369603 |
| (S)-nicotine | multiple interactions | ISO | RGD:733595 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] which results in decreased susceptibility to Nicotine | CTD | PMID:17003101 PMID:17369603 |
| (S)-nicotine | increases expression | ISO | RGD:733595 | 6480464 | Nicotine results in increased expression of ADRB2 mRNA | CTD | PMID:17369603 |
| (S)-nicotine | multiple interactions | ISO | RGD:733595 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Nicotine results in increased expression of PTGS2 protein]; more ... | CTD | PMID:17003101 |
| (S)-timolol (anhydrous) | multiple interactions | ISO | RGD:733595 | 6480464 | Timolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11436944 |
| (S)-timolol (anhydrous) | multiple interactions | ISO | RGD:733595 | 6480464 | [Timolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2060 | 6480464 | Ethinyl Estradiol results in increased expression of ADRB2 mRNA | CTD | PMID:15834898 PMID:12655037 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2060 | 6480464 | Ethinyl Estradiol results in increased expression of ADRB2 mRNA | CTD | PMID:12655037 PMID:15834898 |
| 1H-imidazole | multiple interactions | ISO | RGD:733595 | 6480464 | imidazole promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] | CTD | PMID:17196553 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ADRB2 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ADRB2 mRNA | CTD | PMID:19770486 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| 3',5'-cyclic AMP | increases chemical synthesis | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism results in increased chemical synthesis of Cyclic AMP; more ... | CTD | PMID:21868359 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Alprenolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| 3',5'-cyclic AMP | increases abundance | ISO | RGD:733595 | 6480464 | ADRB2 protein results in increased abundance of Cyclic AMP | CTD | PMID:11562432 |
| 3',5'-cyclic AMP | affects abundance | ISO | RGD:733595 | 6480464 | ADRB2 protein affects the abundance of Cyclic AMP | CTD | PMID:14730417 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Fenoterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 PMID:16980553 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 PMID:12920204 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [salmeterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 PMID:10516654 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Atenolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:10952688 PMID:12920204 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 PMID:10516654 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 PMID:12920204 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10857765 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP] | CTD | PMID:18378355 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [salmeterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:12920204 PMID:10952688 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Fenoterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:16980553 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [ADRB1 protein binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:19419905 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; more ... | CTD | PMID:12920204 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10952688 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Epinephrine binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 PMID:14730417 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [salmeterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 PMID:14730417 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:733595 | 6480464 | bicalutamide inhibits the reaction [Triiodothyronine results in increased expression of ADRB2 protein] | CTD | PMID:18454446 |
| 3,3',5-triiodo-L-thyronine | increases expression | ISO | RGD:733595 | 6480464 | Triiodothyronine results in increased expression of ADRB2 mRNA; more ... | CTD | PMID:18454446 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADRB2 mRNA | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:733595 | 6480464 | [Forskolin co-treated with 1-Methyl-3-isobutylxanthine] promotes the reaction [[ADRB1 protein binds to ADRB2 protein] which results in increased abundance of Cyclic AMP]; more ... | CTD | PMID:19419905 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of ADRB2 mRNA | CTD | PMID:19191707 |
| 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:733595 | 6480464 | decitabine affects the expression of ADRB2 mRNA | CTD | PMID:17194187 |
| 5-azacytidine | affects expression | EXP | | 6480464 | Azacitidine affects the expression of ADRB2 mRNA | CTD | PMID:19002953 |
| acebutolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Acebutolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| acetylsalicylic acid | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 polymorphism affects the susceptibility to Aspirin | CTD | PMID:18159608 |
| acetylsalicylic acid | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 SNP affects the susceptibility to Aspirin | CTD | PMID:18379861 |
| aflatoxin B1 | affects expression | ISO | RGD:733595 | 6480464 | Aflatoxin B1 affects the expression of ADRB2 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:733595 | 6480464 | Aflatoxin B1 results in increased expression of ADRB2 mRNA | CTD | PMID:21641981 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of ADRB2 mRNA | CTD | PMID:19770486 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:10952688 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10952688 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16980553 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10952688 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:10952688 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:12920204 PMID:10952688 |
| albuterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | Albuterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 PMID:16980553 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:12920204 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| albuterol | multiple interactions | ISO | RGD:2060 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Hydroxyindoleacetic Acid | CTD | PMID:2463453 |
| albuterol | multiple interactions | ISO | RGD:2060 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:15467267 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:10952688 PMID:12920204 |
| albuterol | multiple interactions | EXP | | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:19120125 |
| albuterol | decreases expression | ISO | RGD:733595 | 6480464 | Albuterol results in decreased expression of ADRB2 protein | CTD | PMID:16980553 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; more ... | CTD | PMID:12920204 |
| albuterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | Albuterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:16980553 PMID:14722251 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; more ... | CTD | PMID:16980553 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | Albuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16980553 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in decreased abundance of Potassium | CTD | PMID:8102213 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| albuterol | decreases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene polymorphism results in decreased susceptibility to Albuterol | CTD | PMID:15687340 |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 more ... |
| albuterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| alprenolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Alprenolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| alprenolol | multiple interactions | ISO | RGD:733595 | 6480464 | Alprenolol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| alprenolol | multiple interactions | EXP | | 6480464 | Alprenolol inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine]; more ... | CTD | PMID:12198331 |
| alprenolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Alprenolol co-treated with ADRB2 protein] results in increased expression of GNAS protein | CTD | PMID:10455254 |
| amiodarone | decreases expression | ISO | RGD:733595 | 6480464 | Amiodarone results in decreased expression of ADRB2 protein | CTD | PMID:1653643 |
| ammonium chloride | affects expression | ISO | RGD:2060 | 6480464 | Ammonium Chloride affects the expression of ADRB2 mRNA | CTD | PMID:16483693 |
| asbestos | decreases expression | ISO | RGD:733595 | 6480464 | Asbestos results in decreased expression of ADRB2 mRNA | CTD | PMID:22398240 |
| atenolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Atenolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| atenolol | affects binding | ISO | RGD:2060 | 6480464 | Atenolol binds to ADRB2 protein | CTD | PMID:11483288 more ... |
| atenolol | affects binding | ISO | RGD:2060 | 6480464 | Atenolol binds to ADRB2 protein | CTD | PMID:9593075 PMID:11483288 |
| atenolol | affects binding | ISO | RGD:2060 | 6480464 | Atenolol binds to ADRB2 protein | CTD | PMID:2462161 more ... |
| atenolol | multiple interactions | ISO | RGD:2060 | 6480464 | Atenolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11425575 |
| atenolol | increases expression | ISO | RGD:733595 | 6480464 | Atenolol results in increased expression of ADRB2 protein | CTD | PMID:6093157 |
| atenolol | affects binding | ISO | RGD:2060 | 6480464 | Atenolol binds to ADRB2 protein | CTD | PMID:11483288 PMID:9593075 |
| atenolol | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [Albuterol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:12920204 |
| atenolol | affects binding | ISO | RGD:2060 | 6480464 | Atenolol binds to ADRB2 protein | CTD | PMID:11483288 more ... |
| atenolol | multiple interactions | ISO | RGD:2060 | 6480464 | Atenolol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| atenolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Atenolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| beclomethasone | increases expression | ISO | RGD:733595 | 6480464 | Beclomethasone results in increased expression of ADRB2 mRNA | CTD | PMID:15679717 |
| benazepril | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to benazepril | CTD | PMID:15554460 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ADRB2 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:22167199 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium]; more ... | CTD | PMID:22167199 |
| benzo[a]pyrene | affects binding | ISO | RGD:733595 | 6480464 | Benzo(a)pyrene binds to ADRB2 protein | CTD | PMID:22167199 |
| betaxolol | multiple interactions | ISO | RGD:733595 | 6480464 | Betaxolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11436944 |
| betaxolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Betaxolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| bicalutamide | multiple interactions | ISO | RGD:733595 | 6480464 | bicalutamide inhibits the reaction [Triiodothyronine results in increased expression of ADRB2 protein] | CTD | PMID:18454446 |
| bicalutamide | decreases expression | ISO | RGD:733595 | 6480464 | bicalutamide results in decreased expression of ADRB2 mRNA; more ... | CTD | PMID:18454446 |
| bisoprolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Bisoprolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| bisoprolol | increases expression | ISO | RGD:2060 | 6480464 | Bisoprolol results in increased expression of ADRB2 mRNA | CTD | PMID:20668454 |
| bisoprolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Bisoprolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| budesonide | increases expression | EXP | | 6480464 | Budesonide results in increased expression of ADRB2 protein | CTD | PMID:20061444 |
| busulfan | decreases response to substance | EXP | | 6480464 | ADRB2 protein results in decreased susceptibility to Busulfan | CTD | PMID:7202579 |
| calcitriol | decreases expression | ISO | RGD:733595 | 6480464 | Calcitriol results in decreased expression of ADRB2 mRNA | CTD | PMID:16002434 |
| calcium atom | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which affects the abundance of Calcium | CTD | PMID:10372813 |
| calcium atom | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium]; more ... | CTD | PMID:22167199 |
| calcium(0) | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which affects the abundance of Calcium | CTD | PMID:10372813 |
| calcium(0) | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Benzo(a)pyrene results in increased transport of Calcium]; more ... | CTD | PMID:22167199 |
| carteolol | multiple interactions | ISO | RGD:733595 | 6480464 | Carteolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11436944 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | [ADRB1 gene co-treated with ADRB2 gene] affects the susceptibility to carvedilol | CTD | PMID:21395649 |
| carvedilol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to carvedilol | CTD | PMID:12835612 more ... |
| carvedilol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to carvedilol | CTD | PMID:19034036 more ... |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 PMID:12535855 |
| carvedilol | increases uptake | ISO | RGD:733595 | 6480464 | carvedilol results in increased uptake of ADRB2 protein | CTD | PMID:17925438 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | Guanine Nucleotides affects the reaction [carvedilol binds to ADRB2 protein] | CTD | PMID:1378154 |
| carvedilol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to carvedilol | CTD | PMID:12835612 more ... |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:12535855 PMID:14730417 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol inhibits the reaction [CGP 12177 binds to ADRB2 protein] | CTD | PMID:12535855 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | [carvedilol co-treated with ADRB2 protein] results in increased expression of GNAS protein; more ... | CTD | PMID:10455254 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | [carvedilol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:14730417 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:14730417 PMID:16225854 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | [carvedilol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| carvedilol | affects binding | ISO | RGD:733595 | 6480464 | carvedilol binds to ADRB2 protein | CTD | PMID:10372227 PMID:15306222 |
| carvedilol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene SNP affects the susceptibility to carvedilol | CTD | PMID:20352314 |
| carvedilol | increases phosphorylation | ISO | RGD:733595 | 6480464 | carvedilol results in increased phosphorylation of ADRB2 protein | CTD | PMID:17925438 |
| carvedilol | affects binding | ISO | RGD:2060 | 6480464 | carvedilol binds to ADRB2 protein | CTD | PMID:2462161 |
| carvedilol | increases expression | ISO | RGD:2060 | 6480464 | carvedilol results in increased expression of ADRB2 mRNA | CTD | PMID:20668454 PMID:21216836 |
| carvedilol | multiple interactions | ISO | RGD:2060 | 6480464 | carvedilol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| carvedilol | multiple interactions | EXP | | 6480464 | carvedilol inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine]; more ... | CTD | PMID:12198331 |
| carvedilol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to carvedilol | CTD | PMID:19175363 more ... |
| carvedilol | affects binding | ISO | RGD:733595 | 6480464 | carvedilol binds to ADRB2 protein | CTD | PMID:15306222 PMID:10372227 |
| carvedilol | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol binds to and results in decreased activity of ADRB2 protein; more ... | CTD | PMID:16225854 |
| CGP 12177 | affects binding | ISO | RGD:733595 | 6480464 | CGP 12177 binds to ADRB2 protein | CTD | PMID:12535855 |
| CGP 12177 | multiple interactions | ISO | RGD:733595 | 6480464 | carvedilol inhibits the reaction [CGP 12177 binds to ADRB2 protein] | CTD | PMID:12535855 |
| CGP 12177 | multiple interactions | ISO | RGD:2060 | 6480464 | Atenolol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| CGP 12177 | multiple interactions | ISO | RGD:733595 | 6480464 | [CGP 12177 binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| CGP 12177 | affects binding | ISO | RGD:2060 | 6480464 | CGP 12177 binds to ADRB2 protein | CTD | PMID:17628611 more ... |
| chlorpyrifos | affects expression | ISO | RGD:2060 | 6480464 | Chlorpyrifos affects the expression of ADRB2 mRNA | CTD | PMID:18812211 |
| chlorpyrifos | increases expression | ISO | RGD:2060 | 6480464 | Chlorpyrifos results in increased expression of ADRB2 mRNA | CTD | PMID:17452286 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADRB2 mRNA | CTD | PMID:20938992 |
| clenbuterol | multiple interactions | EXP | | 6480464 | [Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose; more ... | CTD | PMID:18552870 |
| clenbuterol | multiple interactions | ISO | RGD:2060 | 6480464 | Clenbuterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16007677 |
| clobenpropit | multiple interactions | ISO | RGD:733595 | 6480464 | clobenpropit promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] | CTD | PMID:17196553 |
| clofibrate | multiple interactions | EXP | | 6480464 | PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ADRB2 mRNA] | CTD | PMID:17585979 |
| cobalt atom | multiple interactions | ISO | RGD:733595 | 6480464 | Cobalt promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:11752207 |
| copper atom | multiple interactions | ISO | RGD:733595 | 6480464 | Copper binds to and results in increased activity of ADRB2 protein | CTD | PMID:16567806 |
| copper(0) | multiple interactions | ISO | RGD:733595 | 6480464 | Copper binds to and results in increased activity of ADRB2 protein | CTD | PMID:16567806 |
| corticosterone | increases expression | ISO | RGD:2060 | 6480464 | Corticosterone results in increased expression of ADRB2 mRNA | CTD | PMID:15755911 |
| crocidolite asbestos | increases expression | ISO | RGD:733595 | 6480464 | Asbestos, Crocidolite results in increased expression of ADRB2 mRNA | CTD | PMID:18687144 |
| cyclosporin A | decreases expression | ISO | RGD:733595 | 6480464 | Cyclosporine results in decreased expression of ADRB2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:733595 | 6480464 | Cyclosporine results in decreased expression of ADRB2 mRNA | CTD | PMID:20106945 PMID:22147139 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of ADRB2 mRNA | CTD | PMID:19770486 |
| D-glucose | multiple interactions | EXP | | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; more ... | CTD | PMID:18552870 |
| DDT | affects activity | ISO | RGD:2060 | 6480464 | DDT affects the activity of ADRB2 protein | CTD | PMID:17157474 |
| dexamethasone | increases expression | ISO | RGD:2060 | 6480464 | Dexamethasone results in increased expression of ADRB2 mRNA | CTD | PMID:9074950 |
| dexamethasone | decreases expression | ISO | RGD:2060 | 6480464 | Dexamethasone results in decreased expression of ADRB2 mRNA | CTD | PMID:21804312 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADRB2 mRNA | CTD | PMID:16054899 |
| dexamethasone | multiple interactions | ISO | RGD:2060 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ADRB2 mRNA] | CTD | PMID:9074950 |
| diazinon | increases expression | ISO | RGD:2060 | 6480464 | Diazinon results in increased expression of ADRB2 mRNA | CTD | PMID:17452286 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | 4-(1H-imidazol-4-ylmethyl)piperidine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; more ... | CTD | PMID:17196553 |
| diazoxide | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:18820136 PMID:21177286 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:10516654 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 more ... |
| diazoxide | increases uptake | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased uptake of ADRB2 protein | CTD | PMID:17925438 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:12920204 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; more ... | CTD | PMID:17925438 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16036225 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:12920204 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | ICI 118551 inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:12920204 PMID:16036225 |
| diazoxide | multiple interactions | ISO | RGD:2060 | 6480464 | [Isoproterenol results in increased activity of ADRB2 protein] which results in increased secretion of Histamine | CTD | PMID:11164953 |
| diazoxide | increases activity | ISO | RGD:2060 | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:11164953 |
| diazoxide | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP] | CTD | PMID:18378355 |
| diazoxide | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:18820136 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of ADRB2 mRNA | CTD | PMID:17350036 |
| diazoxide | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of ADRB2 | CTD | PMID:12963636 |
| diazoxide | multiple interactions | EXP | | 6480464 | CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; more ... | CTD | PMID:18820136 |
| diazoxide | multiple interactions | EXP | | 6480464 | ADRB2 protein affects the reaction [Isoproterenol results in increased expression of IL18 mRNA] | CTD | PMID:15178407 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Ketotifen inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Isoproterenol] | CTD | PMID:10226872 |
| diazoxide | increases phosphorylation | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased phosphorylation of ADRB2 protein | CTD | PMID:16980553 |
| diazoxide | increases expression | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased expression of ADRB2 mRNA | CTD | PMID:19483313 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; more ... | CTD | PMID:16980553 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16980553 more ... |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | ICI 118551 inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:16036225 PMID:12920204 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Cobalt promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:11752207 |
| diazoxide | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:12920204 |
| dichlorine | multiple interactions | ISO | RGD:2060 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of ADRB2 mRNA | CTD | PMID:18636392 |
| dieldrin | affects expression | ISO | RGD:2060 | 6480464 | Dieldrin affects the expression of ADRB2 mRNA | CTD | PMID:18812211 |
| dioxygen | decreases expression | ISO | RGD:2060 | 6480464 | Oxygen results in decreased expression of ADRB2 protein | CTD | PMID:19098126 |
| dobutamine | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene polymorphism affects the susceptibility to Dobutamine | CTD | PMID:17094270 |
| dopamine | multiple interactions | ISO | RGD:2060 | 6480464 | ICI 118551 inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Dopamine] | CTD | PMID:10894789 |
| doxazosin | increases expression | ISO | RGD:2060 | 6480464 | Doxazosin results in increased expression of ADRB2 protein | CTD | PMID:18084315 |
| doxorubicin | affects response to substance | EXP | | 6480464 | ADRB2 affects the susceptibility to Doxorubicin | CTD | PMID:16458323 |
| enalaprilat dihydrate | affects expression | ISO | RGD:2060 | 6480464 | Enalaprilat affects the expression of ADRB2 protein | CTD | PMID:9260993 |
| ethanol | affects expression | ISO | RGD:2060 | 6480464 | Ethanol affects the expression of ADRB2 mRNA | CTD | PMID:11772933 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of ADRB2 mRNA | CTD | PMID:19167417 |
| fenoterol | multiple interactions | ISO | RGD:733595 | 6480464 | Fenoterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:16980553 |
| fenoterol | multiple interactions | ISO | RGD:733595 | 6480464 | Fenoterol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| fenoterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Fenoterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:14730417 PMID:16980553 |
| fenoterol | multiple interactions | ISO | RGD:733595 | 6480464 | Fenoterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:16980553 PMID:14730417 |
| fenoterol | multiple interactions | ISO | RGD:2060 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Fenoterol affects the abundance of Norepinephrine] | CTD | PMID:7969507 |
| fenoterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | Fenoterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 |
| fenoterol | multiple interactions | ISO | RGD:2060 | 6480464 | CGP 20712A inhibits the reaction [[Fenoterol binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine] | CTD | PMID:16474418 |
| fenoterol | multiple interactions | ISO | RGD:733595 | 6480464 | [Fenoterol binds to and results in increased activity of ADRB2 protein] which results in decreased abundance of Potassium | CTD | PMID:8102213 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADRB2 mRNA | CTD | PMID:20938992 |
| fonofos | increases methylation | ISO | RGD:733595 | 6480464 | Fonofos results in increased methylation of ADRB2 promoter | CTD | PMID:22847954 |
| formoterol | multiple interactions | ISO | RGD:733595 | 6480464 | formoterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:16980553 |
| formoterol | multiple interactions | ISO | RGD:733595 | 6480464 | formoterol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| formoterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | formoterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:16980553 PMID:14722251 |
| formoterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | formoterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 PMID:16980553 |
| formoterol | multiple interactions | EXP | | 6480464 | formoterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:20061444 |
| furan | increases methylation | ISO | RGD:2060 | 6480464 | furan results in increased methylation of ADRB2 gene | CTD | PMID:22079235 |
| glucose | multiple interactions | EXP | | 6480464 | [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; more ... | CTD | PMID:18552870 |
| gold atom | multiple interactions | EXP | | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA | CTD | PMID:19695318 |
| gold(0) | multiple interactions | EXP | | 6480464 | [Gold co-treated with Polyethylene Glycols] results in increased expression of ADRB2 mRNA | CTD | PMID:19695318 |
| histamine | multiple interactions | ISO | RGD:733595 | 6480464 | Histamine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein] | CTD | PMID:17196553 |
| histamine | multiple interactions | EXP | | 6480464 | Alprenolol inhibits the reaction [ADRB2 results in decreased susceptibility to Histamine]; more ... | CTD | PMID:12198331 |
| histamine | decreases response to substance | EXP | | 6480464 | ADRB2 results in decreased susceptibility to Histamine | CTD | PMID:12198331 |
| histamine | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] which results in increased secretion of Histamine; more ... | CTD | PMID:11164953 |
| histamine | increases activity | ISO | RGD:733595 | 6480464 | Histamine results in increased activity of ADRB2 protein | CTD | PMID:17196553 |
| imipramine | decreases expression | ISO | RGD:733595 | 6480464 | Imipramine results in decreased expression of ADRB2 protein | CTD | PMID:10618463 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | 4-(1H-imidazol-4-ylmethyl)piperidine promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; more ... | CTD | PMID:17196553 |
| isoprenaline | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:18820136 PMID:21177286 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:10516654 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | ICI 118551 inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:12920204 PMID:16036225 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:14730417 more ... |
| isoprenaline | increases uptake | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased uptake of ADRB2 protein | CTD | PMID:17925438 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:16980553 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:12920204 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to ADRB2 protein] which results in increased phosphorylation of MAPK3 protein; more ... | CTD | PMID:17925438 |
| isoprenaline | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Isoproterenol results in increased abundance of Cyclic AMP] | CTD | PMID:18378355 |
| isoprenaline | increases activity | ISO | RGD:2060 | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:11164953 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of ADRB2 mRNA | CTD | PMID:17350036 |
| isoprenaline | decreases expression | EXP | | 6480464 | Isoproterenol results in decreased expression of ADRB2 | CTD | PMID:12963636 |
| isoprenaline | multiple interactions | EXP | | 6480464 | CAV1 protein promotes the reaction [Isoproterenol results in increased activity of ADRB2 protein]; more ... | CTD | PMID:18820136 |
| isoprenaline | multiple interactions | EXP | | 6480464 | ADRB2 protein affects the reaction [Isoproterenol results in increased expression of IL18 mRNA] | CTD | PMID:15178407 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Ketotifen inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Isoproterenol] | CTD | PMID:10226872 |
| isoprenaline | increases phosphorylation | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased phosphorylation of ADRB2 protein | CTD | PMID:16980553 |
| isoprenaline | increases expression | ISO | RGD:733595 | 6480464 | Isoproterenol results in increased expression of ADRB2 mRNA | CTD | PMID:19483313 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; more ... | CTD | PMID:16980553 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Isoproterenol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:12920204 more ... |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Isoproterenol binds to and results in increased activity of ADRB2 protein | CTD | PMID:16036225 more ... |
| isoprenaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Isoproterenol results in increased activity of ADRB2 protein] which results in increased secretion of Histamine | CTD | PMID:11164953 |
| isoprenaline | increases activity | EXP | | 6480464 | Isoproterenol results in increased activity of ADRB2 protein | CTD | PMID:18820136 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | ICI 118551 inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:16036225 PMID:12920204 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Cobalt promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:11752207 |
| isoprenaline | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:12920204 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ADRB2 mRNA | CTD | PMID:20938992 |
| labetalol | decreases activity | ISO | RGD:733595 | 6480464 | Labetalol results in decreased activity of ADRB2 protein | CTD | PMID:2567112 |
| labetalol | affects binding | ISO | RGD:2060 | 6480464 | Labetalol binds to ADRB2 protein | CTD | PMID:11483288 PMID:2462161 |
| labetalol | multiple interactions | ISO | RGD:2060 | 6480464 | Labetalol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| labetalol | affects binding | ISO | RGD:2060 | 6480464 | Labetalol binds to ADRB2 protein | CTD | PMID:2462161 PMID:11483288 |
| labetalol | multiple interactions | ISO | RGD:733595 | 6480464 | [Labetalol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| labetalol | multiple interactions | ISO | RGD:2060 | 6480464 | Labetalol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11425575 |
| labetalol | affects binding | ISO | RGD:2060 | 6480464 | Labetalol binds to ADRB2 protein | CTD | PMID:11483288 |
| losartan | affects expression | ISO | RGD:2060 | 6480464 | Losartan affects the expression of ADRB2 protein | CTD | PMID:9260993 |
| metoprolol | affects binding | ISO | RGD:2060 | 6480464 | Metoprolol binds to ADRB2 protein | CTD | PMID:9593075 |
| metoprolol | multiple interactions | ISO | RGD:733595 | 6480464 | Metoprolol binds to and results in decreased activity of ADRB2 protein; more ... | CTD | PMID:14730417 |
| metoprolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Metoprolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| metoprolol | multiple interactions | ISO | RGD:2060 | 6480464 | Metoprolol promotes the reaction [Streptozocin results in increased expression of ADRB2 protein] | CTD | PMID:18703049 |
| metoprolol | increases expression | ISO | RGD:2060 | 6480464 | Metoprolol results in increased expression of ADRB2 protein | CTD | PMID:18703049 |
| metoprolol | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene polymorphism affects the susceptibility to Metoprolol | CTD | PMID:17671401 |
| metoprolol | increases expression | EXP | | 6480464 | Metoprolol results in increased expression of ADRB2 mRNA | CTD | PMID:20675662 |
| mifepristone | multiple interactions | ISO | RGD:2060 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ADRB2 mRNA] | CTD | PMID:9074950 |
| nadolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Nadolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| nickel atom | affects expression | ISO | RGD:2060 | 6480464 | Nickel affects the expression of ADRB2 mRNA | CTD | PMID:18812211 |
| nitric oxide | decreases abundance | EXP | | 6480464 | ADRB2 protein results in decreased abundance of Nitric Oxide | CTD | PMID:10580815 |
| octopamine | multiple interactions | ISO | RGD:733595 | 6480464 | Octopamine inhibits the reaction [Norepinephrine binds to ADRB2 protein] | CTD | PMID:10344530 |
| ozone | affects response to substance | EXP | | 6480464 | ADRB2 protein affects the susceptibility to Ozone | CTD | PMID:10926562 |
| ozone | multiple interactions | ISO | RGD:2060 | 6480464 | [Ozone co-treated with Chlorine] affects the expression of ADRB2 mRNA | CTD | PMID:18636392 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of ADRB2 mRNA; more ... | CTD | PMID:17585979 |
| parathion | increases methylation | ISO | RGD:733595 | 6480464 | Parathion results in increased methylation of ADRB2 promoter | CTD | PMID:22847954 |
| perfluorooctanoic acid | increases expression | ISO | RGD:2060 | 6480464 | perfluorooctanoic acid results in increased expression of ADRB2 mRNA | CTD | PMID:19162173 |
| phenylephrine | multiple interactions | ISO | RGD:2060 | 6480464 | CGP 20712A inhibits the reaction [[Fenoterol binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; more ... | CTD | PMID:16474418 |
| phorbol 13-acetate 12-myristate | increases phosphorylation | ISO | RGD:733595 | 6480464 | Tetradecanoylphorbol Acetate results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 |
| pindolol | decreases expression | ISO | RGD:733595 | 6480464 | Pindolol results in decreased expression of ADRB2 protein | CTD | PMID:2175014 |
| pindolol | multiple interactions | ISO | RGD:733595 | 6480464 | Pindolol binds to and results in decreased activity of ADRB2 protein; more ... | CTD | PMID:14730417 |
| pindolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Pindolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| pindolol | affects binding | ISO | RGD:2060 | 6480464 | Pindolol binds to ADRB2 protein | CTD | PMID:2462161 |
| pindolol | multiple interactions | ISO | RGD:2060 | 6480464 | Pindolol inhibits the reaction [CGP 12177 binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ADRB2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ADRB2 mRNA | CTD | PMID:18445702 |
| potassium atom | multiple interactions | ISO | RGD:733595 | 6480464 | [Albuterol binds to and results in increased activity of ADRB2 protein] which results in decreased abundance of Potassium; more ... | CTD | PMID:8102213 |
| potassium atom | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Potassium | CTD | PMID:17292646 |
| potassium atom | multiple interactions | ISO | RGD:733595 | 6480464 | [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of [ADRB1 protein binds to ADRB2 protein]] affects the reaction [KCNH2 protein results in increased transport of Potassium] | CTD | PMID:19419905 |
| practolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Practolol binds to ADRB2 protein] which results in increased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| progesterone | increases expression | ISO | RGD:2060 | 6480464 | Progesterone results in increased expression of ADRB2 mRNA | CTD | PMID:15985637 |
| propafenone | multiple interactions | ISO | RGD:733595 | 6480464 | Propafenone binds to and results in decreased activity of ADRB2 protein | CTD | PMID:6141285 |
| propranolol | decreases expression | ISO | RGD:733595 | 6480464 | Propranolol results in decreased expression of ADRB2 mRNA | CTD | PMID:15603589 |
| propranolol | multiple interactions | ISO | RGD:2060 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:2897299 PMID:11425575 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:6141285 more ... |
| propranolol | affects binding | ISO | RGD:2060 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:11483288 more ... |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:10952688 more ... |
| propranolol | affects binding | ISO | RGD:733595 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:2169833 PMID:10372227 |
| propranolol | increases expression | ISO | RGD:2060 | 6480464 | Propranolol results in increased expression of ADRB2 mRNA | CTD | PMID:20668454 |
| propranolol | multiple interactions | ISO | RGD:2060 | 6480464 | Propranolol inhibits the reaction [Dihydroalprenolol binds to ADRB2 protein]; more ... | CTD | PMID:2462161 |
| propranolol | affects binding | ISO | RGD:2060 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:11483288 more ... |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Propranolol co-treated with ADRB2 protein] results in increased expression of GNAS protein; more ... | CTD | PMID:10455254 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:10952688 more ... |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Propranolol binds to and results in decreased activity of ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:14730417 |
| propranolol | affects binding | ISO | RGD:733595 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:10372227 PMID:2169833 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | [Propranolol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP; more ... | CTD | PMID:17925438 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:12920204 PMID:10952688 |
| propranolol | affects binding | ISO | RGD:2060 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:11483288 PMID:9593075 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:6141285 PMID:10952688 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [[Albuterol binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP] | CTD | PMID:10952688 PMID:12920204 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol inhibits the reaction [Albuterol binds to and results in increased activity of ADRB2 protein]; more ... | CTD | PMID:12920204 |
| propranolol | affects binding | ISO | RGD:733595 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:2169833 |
| propranolol | multiple interactions | ISO | RGD:733595 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:10952688 PMID:6141285 |
| propranolol | multiple interactions | ISO | RGD:2060 | 6480464 | Propranolol binds to and results in decreased activity of ADRB2 protein | CTD | PMID:11425575 PMID:2897299 |
| propranolol | affects binding | ISO | RGD:2060 | 6480464 | Propranolol binds to ADRB2 protein | CTD | PMID:9593075 PMID:11483288 |
| prostaglandin E1 | increases phosphorylation | ISO | RGD:733595 | 6480464 | Alprostadil results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 |
| prostaglandin E2 | multiple interactions | ISO | RGD:733595 | 6480464 | [ICI 118551 binds to and results in decreased activity of ADRB2 protein] inhibits the reaction [Nicotine results in increased abundance of Dinoprostone] | CTD | PMID:17369603 |
| putrescine | multiple interactions | ISO | RGD:733595 | 6480464 | Putrescine binds to and results in increased activity of ADRB2 protein | CTD | PMID:20885010 |
| reserpine | increases expression | ISO | RGD:2060 | 6480464 | Reserpine results in increased expression of ADRB2 mRNA | CTD | PMID:1664493 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADRB2 mRNA | CTD | PMID:16054899 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | salmeterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:10516654 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | salmeterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:10516654 PMID:14730417 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | salmeterol inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | salmeterol binds to and results in increased activity of ADRB2 protein; more ... | CTD | PMID:14730417 PMID:10516654 |
| salmeterol | multiple interactions | ISO | RGD:2060 | 6480464 | CGP 20712A inhibits the reaction [[salmeterol binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; more ... | CTD | PMID:16474418 |
| salmeterol | multiple interactions | EXP | | 6480464 | salmeterol binds to and results in increased activity of ADRB2 protein | CTD | PMID:20061444 |
| salmeterol | increases phosphorylation | ISO | RGD:733595 | 6480464 | salmeterol results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 |
| salmeterol | decreases expression | ISO | RGD:733595 | 6480464 | salmeterol results in decreased expression of ADRB2 protein | CTD | PMID:16980553 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | [salmeterol binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein; more ... | CTD | PMID:16980553 |
| salmeterol | multiple interactions | ISO | RGD:733595 | 6480464 | [salmeterol binds to ADRB2 protein] which results in increased expression of CFTR protein | CTD | PMID:12621035 |
| silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of ADRB2 mRNA | CTD | PMID:19073995 |
| sodium atom | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] which results in increased transport of Sodium | CTD | PMID:20054151 |
| sotalol | affects binding | ISO | RGD:733595 | 6480464 | Sotalol binds to ADRB2 protein | CTD | PMID:2169833 |
| sotalol | multiple interactions | ISO | RGD:733595 | 6480464 | [Sotalol binds to ADRB2 protein] which results in decreased abundance of Cyclic AMP | CTD | PMID:17925438 |
| spermidine | affects binding | ISO | RGD:733595 | 6480464 | Spermidine binds to ADRB2 protein | CTD | PMID:20885010 |
| spermine | affects binding | ISO | RGD:733595 | 6480464 | Spermine binds to ADRB2 protein | CTD | PMID:20885010 |
| streptozocin | increases expression | ISO | RGD:2060 | 6480464 | Streptozocin results in increased expression of ADRB2 protein | CTD | PMID:18703049 |
| streptozocin | multiple interactions | ISO | RGD:2060 | 6480464 | Metoprolol promotes the reaction [Streptozocin results in increased expression of ADRB2 protein] | CTD | PMID:18703049 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of ADRB2 mRNA | CTD | PMID:20937368 |
| terbufos | increases methylation | ISO | RGD:733595 | 6480464 | terbufos results in increased methylation of ADRB2 promoter | CTD | PMID:22847954 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] inhibits the reaction [Shiga Toxin 2 results in increased activity of CASP7 protein]; more ... | CTD | PMID:12826277 |
| terbutaline | increases phosphorylation | ISO | RGD:733595 | 6480464 | Terbutaline results in increased phosphorylation of ADRB2 protein | CTD | PMID:14722251 PMID:16980553 |
| terbutaline | decreases expression | ISO | RGD:733595 | 6480464 | Terbutaline results in decreased expression of ADRB2 protein | CTD | PMID:1280742 PMID:16980553 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein; more ... | CTD | PMID:16980553 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which affects the abundance of Calcium | CTD | PMID:10372813 |
| terbutaline | affects binding | ISO | RGD:2060 | 6480464 | Terbutaline binds to ADRB2 protein | CTD | PMID:19098126 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | Terbutaline binds to and results in increased activity of ADRB2 protein | CTD | PMID:10094932 more ... |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | ICI 118551 inhibits the reaction [Terbutaline results in increased activity of ADRB2 protein]; more ... | CTD | PMID:20054151 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | CGP 20712A inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Phenylephrine]; more ... | CTD | PMID:16474418 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] | CTD | PMID:10857765 PMID:11096136 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | Terbutaline inhibits the reaction [cyanopindolol binds to ADRB2 protein] | CTD | PMID:14730417 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10516654 more ... |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | Terbutaline binds to and results in increased activity of ADRB2 protein | CTD | PMID:10229127 more ... |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Potassium | CTD | PMID:17292646 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | Ketotifen inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased susceptibility to Isoproterenol] | CTD | PMID:10226872 |
| terbutaline | increases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein SNP results in increased susceptibility to Terbutaline | CTD | PMID:20519311 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased activity of MAPK3 protein]]; more ... | CTD | PMID:10469353 |
| terbutaline | multiple interactions | EXP | | 6480464 | ADRB2 protein promotes the reaction [Terbutaline results in increased secretion of SFTPC protein]; more ... | CTD | PMID:14565945 |
| terbutaline | multiple interactions | EXP | | 6480464 | Terbutaline binds to and results in increased activity of ADRB2 protein | CTD | PMID:17430990 PMID:20061444 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline results in increased secretion of GAST protein] | CTD | PMID:9277405 |
| terbutaline | increases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein results in increased susceptibility to Terbutaline | CTD | PMID:16395068 |
| terbutaline | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein polymorphism affects the susceptibility to Terbutaline | CTD | PMID:12563174 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline promotes the reaction [Lipopolysaccharides results in increased expression of IL8 protein]] | CTD | PMID:9258252 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline results in decreased activity of NFKB1 protein] | CTD | PMID:11675405 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | ADRB2 gene polymorphism affects the reaction [Terbutaline results in increased metabolism of Lipids]; more ... | CTD | PMID:11429395 |
| terbutaline | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene polymorphism affects the susceptibility to Terbutaline | CTD | PMID:16395068 |
| terbutaline | affects response to substance | ISO | RGD:733595 | 6480464 | ADRB2 protein affects the susceptibility to Terbutaline | CTD | PMID:16153394 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | ICI 118551 inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Levodopa]; more ... | CTD | PMID:10894789 |
| terbutaline | multiple interactions | ISO | RGD:733595 | 6480464 | Atenolol inhibits the reaction [[Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP]; more ... | CTD | PMID:12920204 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | ADRB2 protein promotes the reaction [Terbutaline inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; more ... | CTD | PMID:11096136 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] which results in increased secretion of Histamine | CTD | PMID:11164953 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline binds to and results in increased activity of ADRB2 protein] which results in increased expression of TNF protein | CTD | PMID:10094932 |
| terbutaline | increases activity | ISO | RGD:2060 | 6480464 | Terbutaline results in increased activity of ADRB2 protein | CTD | PMID:11164953 PMID:20054151 |
| terbutaline | multiple interactions | ISO | RGD:2060 | 6480464 | [Terbutaline results in increased activity of ADRB2 protein] which results in increased abundance of Cyclic AMP | CTD | PMID:10857765 |
| vincristine | increases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene SNP results in increased susceptibility to Vincristine | CTD | PMID:20864405 PMID:21245421 |
| vincristine | increases response to substance | ISO | RGD:733595 | 6480464 | ADRB2 gene SNP results in increased susceptibility to Vincristine | CTD | PMID:21245421 PMID:20864405 |
| zinc atom | multiple interactions | ISO | RGD:733595 | 6480464 | Zinc binds to and results in increased activity of ADRB2 protein | CTD | PMID:16567806 |
| zinc atom | multiple interactions | ISO | RGD:733595 | 6480464 | Zinc promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:11752207 |
| zinc(0) | multiple interactions | ISO | RGD:733595 | 6480464 | Zinc binds to and results in increased activity of ADRB2 protein | CTD | PMID:16567806 |
| zinc(0) | multiple interactions | ISO | RGD:733595 | 6480464 | Zinc promotes the reaction [Isoproterenol binds to and results in increased activity of ADRB2 protein] | CTD | PMID:11752207 |